Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2018 Filed Feb 15, 2018 00:48 UTC |
HOLT VICTORIA MDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,151 | $0.00 Strike: $105.75 | $0.00 |
DisclosureSEC source: 0001437749-18-002615 · rdgdoc.xml · derivative · entry 2 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,151 Underlying: Common Stock · 7,151 shares Expires 2028-02-12 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2019. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:48 UTC |
HOLT VICTORIA MDirector · President and CEO
|
GrantCommon Stock | 6,242 | $105.75 | $660,091.50 |
DisclosureSEC source: 0001437749-18-002615 · rdgdoc.xml · nonDerivative · entry 1 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,235 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2019. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:54 UTC |
FEIN DAVID MChief Revenue Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,682 | $0.00 Strike: $105.75 | $0.00 |
DisclosureSEC source: 0001437749-18-002617 · rdgdoc.xml · derivative · entry 2 FEIN DAVID M · CIK 0001626274 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,682 Underlying: Common Stock · 2,682 shares Expires 2028-02-12 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2019. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:54 UTC |
FEIN DAVID MChief Revenue Officer
|
GrantCommon Stock | 2,341 | $105.75 | $247,560.75 |
DisclosureSEC source: 0001437749-18-002617 · rdgdoc.xml · nonDerivative · entry 1 FEIN DAVID M · CIK 0001626274 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,847 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2019. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person as of February 14, 2018, including 226 shares purchased on November 15, 2017 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:49 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,004 | $0.00 Strike: $105.75 | $0.00 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · derivative · entry 4 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,004 Underlying: Common Stock · 3,004 shares Expires 2028-02-12 F5 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2019. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:49 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantCommon Stock | 2,622 | $105.75 | $277,276.50 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2019. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person as of February 14, 2018, including a total of 555 shares of Common Stock of the issuer purchased by the reporting person through the issuer's Employee Stock Purchase Plan program on May 15, 2017 and November 15, 2017. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:48 UTC |
WAY JOHNChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,291 | $0.00 Strike: $105.75 | $0.00 |
DisclosureSEC source: 0001437749-18-002614 · rdgdoc.xml · derivative · entry 2 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,291 Underlying: Common Stock · 4,291 shares Expires 2028-02-12 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2019. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:48 UTC |
WAY JOHNChief Financial Officer
|
GrantCommon Stock | 3,745 | $105.75 | $396,033.75 |
DisclosureSEC source: 0001437749-18-002614 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,865 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2019. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person as of February 14, 2018, including a total of 445 shares of Common Stock of the issuer purchased by the reporting person through the issuer's Employee Stock Purchase Plan program on May 15, 2017, and November 15, 2017. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:47 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,218 | $0.00 Strike: $105.75 | $0.00 |
DisclosureSEC source: 0001437749-18-002613 · rdgdoc.xml · derivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Underlying: Common Stock · 3,218 shares Expires 2028-02-12 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2019. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:47 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantCommon Stock | 2,809 | $105.75 | $297,051.75 |
DisclosureSEC source: 0001437749-18-002613 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,214 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2019. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person as of February 14, 2018, including a total of 870 shares of Common Stock of the issuer purchased by the reporting person through the issuer's Employee Stock Purchase Plan program on May 15, 2017 and November 15, 2017. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:04 UTC |
Goodman John BDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,715 | $0.00 Strike: $53.34 | $0.00 |
DisclosureSEC source: 0001437749-18-002602 · rdgdoc.xml · derivative · entry 3 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,715 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:04 UTC |
Goodman John BDirector
|
SaleCommon Stock | 2,715 | $106.79 | $289,941.91 |
DisclosureSEC source: 0001437749-18-002602 · rdgdoc.xml · nonDerivative · entry 2 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,514 F1 · price: Reflects the weighted average price of 2,715 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 12, 2018 with sale prices ranging from $106.50 to $107.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:04 UTC |
Goodman John BDirector
|
Exercise / conversionCommon Stock | 2,715 | $53.34 | $144,818.10 |
DisclosureSEC source: 0001437749-18-002602 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:17 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-18-000267 · rdgdoc.xml · derivative · entry 3 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 500 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:17 UTC |
Gawlick RainerDirector
|
SaleCommon Stock | 500 | $102.75 | $51,375.00 |
DisclosureSEC source: 0001437749-18-000267 · rdgdoc.xml · nonDerivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,425 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:17 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 500 | $5.56 | $2,780.00 |
DisclosureSEC source: 0001437749-18-000267 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 22:09 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $36.41 | $0.00 |
DisclosureSEC source: 0001437749-17-020657 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 22:09 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 4,000 | $94.79 | $379,148.00 |
DisclosureSEC source: 0001437749-17-020657 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,578 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F2 · price: Reflects the weighted average price of 4,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on December 11, 2017 with sale prices ranging from $94.50 to $95.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 22:09 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 4,000 | $36.41 | $145,640.00 |
DisclosureSEC source: 0001437749-17-020657 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 21:41 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-17-020340 · rdgdoc.xml · derivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 21:41 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 5,000 | $5.56 | $27,800.00 |
DisclosureSEC source: 0001437749-17-020340 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2017 Filed Feb 21, 2018 21:34 UTC |
WAY JOHNChief Financial Officer
|
Tax withholdingCommon Stock | 214 | $103.00 | $22,042.00 |
DisclosureSEC source: 0001437749-18-002988 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,503 Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 22:33 UTC |
Tumelty John B.VP/GM & Managing Director-EMEA
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,891 | $0.00 Strike: $57.88 | $0.00 |
DisclosureSEC source: 0001437749-17-019827 · rdgdoc.xml · derivative · entry 7 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,564 Underlying: Common Stock · 1,891 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2017. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 22:33 UTC |
Tumelty John B.VP/GM & Managing Director-EMEA
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,898 | $0.00 Strike: $67.15 | $0.00 |
DisclosureSEC source: 0001437749-17-019827 · rdgdoc.xml · derivative · entry 6 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,847 Underlying: Common Stock · 1,898 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2016. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 22:33 UTC |
Tumelty John B.VP/GM & Managing Director-EMEA
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,341 | $0.00 Strike: $78.59 | $0.00 |
DisclosureSEC source: 0001437749-17-019827 · rdgdoc.xml · derivative · entry 5 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,894 Underlying: Common Stock · 7,341 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2015. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 22:33 UTC |
Tumelty John B.VP/GM & Managing Director-EMEA
|
SaleCommon Stock | 13,556 | $92.07 | $1,248,111.76 |
DisclosureSEC source: 0001437749-17-019827 · rdgdoc.xml · nonDerivative · entry 4 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,873 F1 · price: Reflects the weighted average price of 13,556 shares of common stock of Proto Labs, Inc. sold by the reporting person on November 22, 2017 with sale prices ranging from $91.50 to $92.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 22:33 UTC |
Tumelty John B.VP/GM & Managing Director-EMEA
|
Exercise / conversionCommon Stock | 1,891 | $57.88 | $109,451.08 |
DisclosureSEC source: 0001437749-17-019827 · rdgdoc.xml · nonDerivative · entry 3 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 22:33 UTC |
Tumelty John B.VP/GM & Managing Director-EMEA
|
Exercise / conversionCommon Stock | 1,898 | $67.15 | $127,450.70 |
DisclosureSEC source: 0001437749-17-019827 · rdgdoc.xml · nonDerivative · entry 2 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 22:33 UTC |
Tumelty John B.VP/GM & Managing Director-EMEA
|
Exercise / conversionCommon Stock | 7,341 | $78.59 | $576,929.19 |
DisclosureSEC source: 0001437749-17-019827 · rdgdoc.xml · nonDerivative · entry 1 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2017 Filed Nov 30, 2017 15:43 UTC Amendment |
Tumelty John B.VP/GM & Managing Director-EMEA
|
SaleCommon Stock | 13,556 | $92.07 | $1,248,111.76 |
DisclosureSEC source: 0001437749-17-019992 · rdgdoc.xml · nonDerivative · entry 4 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,769 F2 · price: Reflects the weighted average price of 13,556 shares of common stock of Proto Labs, Inc. sold by the reporting person on November 22, 2017 with sale prices ranging from $91.50 to $92.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 22, 2017 Filed Nov 30, 2017 15:43 UTC Amendment |
Tumelty John B.VP/GM & Managing Director-EMEA
|
Exercise / conversionCommon Stock | 1,891 | $57.88 | $109,451.08 |
DisclosureSEC source: 0001437749-17-019992 · rdgdoc.xml · nonDerivative · entry 3 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2017 Filed Nov 30, 2017 15:43 UTC Amendment |
Tumelty John B.VP/GM & Managing Director-EMEA
|
Exercise / conversionCommon Stock | 1,898 | $67.15 | $127,450.70 |
DisclosureSEC source: 0001437749-17-019992 · rdgdoc.xml · nonDerivative · entry 2 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2017 Filed Nov 30, 2017 15:43 UTC Amendment |
Tumelty John B.VP/GM & Managing Director-EMEA
|
Exercise / conversionCommon Stock | 7,341 | $78.59 | $576,929.19 |
DisclosureSEC source: 0001437749-17-019992 · rdgdoc.xml · nonDerivative · entry 1 Tumelty John B. · CIK 0001542616 · VP/GM & Managing Director-EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This filing amends Table I to correct the balances set forth in Column 5 thereof. Read SEC document |
| November 21, 2017 Filed Nov 21, 2017 18:57 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-17-019671 · rdgdoc.xml · derivative · entry 3 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 1,500 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| November 21, 2017 Filed Nov 21, 2017 18:57 UTC |
Gawlick RainerDirector
|
SaleCommon Stock | 1,500 | $90.31 | $135,472.05 |
DisclosureSEC source: 0001437749-17-019671 · rdgdoc.xml · nonDerivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,425 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. F3 · price: Reflects the weighted average price of 1,500 shares of common stock of Proto Labs, Inc. sold by the reporting person on November 21, 2017 with sale prices ranging from $90.20 to $90.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 21, 2017 Filed Nov 21, 2017 18:57 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 1,500 | $5.56 | $8,340.00 |
DisclosureSEC source: 0001437749-17-019671 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. Read SEC document |
| October 26, 2017 Filed Nov 3, 2017 19:50 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,891 | $0.00 Strike: $57.88 | $0.00 |
DisclosureSEC source: 0001437749-17-018261 · rdgdoc.xml · derivative · entry 6 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,564 Underlying: Common Stock · 1,891 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2017. Read SEC document |
| October 26, 2017 Filed Nov 3, 2017 19:50 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 1,891 | $85.90 | $162,432.55 |
DisclosureSEC source: 0001437749-17-018261 · rdgdoc.xml · nonDerivative · entry 4 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,578 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F3 · price: Reflects the weighted average price of 1,891 shares of common stock of Proto Labs, Inc. sold by the reporting person on October 26, 2017 with sale prices ranging from $85.45 to $86.25 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 26, 2017 Filed Nov 3, 2017 19:50 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 1,891 | $57.88 | $109,451.08 |
DisclosureSEC source: 0001437749-17-018261 · rdgdoc.xml · nonDerivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2017 Filed Nov 3, 2017 19:50 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $36.41 | $0.00 |
DisclosureSEC source: 0001437749-17-018261 · rdgdoc.xml · derivative · entry 5 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on December 11, 2013. Read SEC document |
| September 29, 2017 Filed Nov 3, 2017 19:50 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 4,000 | $80.00 | $320,011.60 |
DisclosureSEC source: 0001437749-17-018261 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,578 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F2 · price: Reflects the weighted average price of 4,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 29, 2017 with sale prices ranging from $80.00 to $80.10 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 29, 2017 Filed Nov 3, 2017 19:50 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 4,000 | $36.41 | $145,640.00 |
DisclosureSEC source: 0001437749-17-018261 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2017 Filed Jul 31, 2017 21:16 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 741 | $0.00 Strike: $36.41 | $0.00 |
DisclosureSEC source: 0001437749-17-013390 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 741 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on December 11, 2013. Read SEC document |
| July 27, 2017 Filed Jul 31, 2017 21:16 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 741 | $73.84 | $54,715.07 |
DisclosureSEC source: 0001437749-17-013390 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,578 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F2 · price: Reflects the weighted average price of 741 shares of common stock of Proto Labs, Inc. sold by the reporting person on July 27, 2017 with sale prices ranging from $73.65 to $73.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 27, 2017 Filed Jul 31, 2017 21:16 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 741 | $36.41 | $26,979.81 |
DisclosureSEC source: 0001437749-17-013390 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 20:03 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,259 | $0.00 Strike: $36.41 | $0.00 |
DisclosureSEC source: 0001437749-17-012933 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,741 Underlying: Common Stock · 3,259 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on December 11, 2013. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 20:03 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 3,259 | $72.02 | $234,710.90 |
DisclosureSEC source: 0001437749-17-012933 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,578 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F2 · price: Reflects the weighted average price of 3,259 shares of common stock of Proto Labs, Inc. sold by the reporting person on July 19, 2017 with sale prices ranging from $72.00 to $72.10 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 20:03 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionCommon Stock | 3,259 | $36.41 | $118,660.19 |
DisclosureSEC source: 0001437749-17-012933 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 20:30 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $36.41 | $0.00 |
DisclosureSEC source: 0001437749-17-011139 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 4,000 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning in December 11, 2013. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 20:30 UTC |
Bodor RobertVP/General Manager-Americas
|
SaleCommon Stock | 4,000 | $66.01 | $264,032.80 |
DisclosureSEC source: 0001437749-17-011139 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,578 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F3 · price: Reflects the weighted average price of 4,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on June 8, 2017, with sale prices ranging from $66.00 to $66.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.